Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid and Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05364086
What this trial is testing

An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of Rochester NCORP Research Base 2,100
Testing effectiveness (Phase 2)Study completedNCT01531894
What this trial is testing

Continuation Study of the Oral AKT Inhibitor GSK2110183

Who this might be right for
Cancer
Novartis Pharmaceuticals 11
Not applicableLooking for participantsNCT06897137
What this trial is testing

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Who this might be right for
Malignant Solid NeoplasmHematopoietic NeoplasmsLymphatic System Neoplasm
Wake Forest University Health Sciences 3,000
Not applicableStudy completedNCT06062901
What this trial is testing

An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 28
Very early researchStudy completedNCT04742595
What this trial is testing

Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
M.D. Anderson Cancer Center 32
Early research (Phase 1)Study completedNCT02660281
What this trial is testing

URMC Related Haplo-identical Donor BMT

Who this might be right for
Hematological DiseaseImmune DeficienciesSolid Tumors+3 more
University of Rochester 74
Testing effectiveness (Phase 2)Study completedNCT04983901
What this trial is testing

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT02187783
What this trial is testing

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)

Who this might be right for
Tumors With CDK4/6 Pathway Activation
Novartis Pharmaceuticals 106
Not applicableLooking for participantsNCT06089408
What this trial is testing

Weighted Blanket Use to Reduce Anxiety in Oncology Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 114
Not applicableActive Not RecruitingNCT06106360
What this trial is testing

A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

Who this might be right for
Solid TumorHematological Malignancy
Inova Health Care Services 53
Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Not applicableStudy completedNCT03980535
What this trial is testing

New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 273
Testing effectiveness (Phase 2)Study completedNCT01885195
What this trial is testing

MEK162 for Patients With RAS/RAF/MEK Activated Tumors

Who this might be right for
Solid Tumor and Hematologic Malignancies
Pfizer 110
Early research (Phase 1)Looking for participantsNCT06484816
What this trial is testing

TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorHematologic Malignancy
Shenzhen TargetRx Co., Ltd. 90
Not applicableLooking for participantsNCT05695638
What this trial is testing

Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment

Who this might be right for
Solid Tumor, Unspecified, AdultHaematological Malignancy
Morten Ladekarl 3,000
Early research (Phase 1)Study completedNCT04886622
What this trial is testing

DT2216 in Relapsed/Refractory Malignancies

Who this might be right for
Solid TumorHematologic Malignancy
Dialectic Therapeutics, Inc 20
Early research (Phase 1)Looking for participantsNCT02508038
What this trial is testing

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more
University of Wisconsin, Madison 22
Not applicableStudy completedNCT04630015
What this trial is testing

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of California, San Francisco 134
Very early researchEnded earlyNCT03579446
What this trial is testing

Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
M.D. Anderson Cancer Center 43
Early research (Phase 1)Ended earlyNCT00089089
What this trial is testing

Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas

Who this might be right for
Hematopoietic/Lymphoid CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 42
Next Page